1. Sim S, Choi Y, Park HS. Immunologic basis of type 2 biologics for severe asthma. Immune Netw 2022;22:e45.

2. Nurmagambetov T, Kuwahara R, Garbe P. The economic burden of asthma in the United States, 2008-2013. Ann Am Thorac Soc 2018;15:348–356.

3. Kuruvilla ME, Lee FE, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol 2019;56:219–233.

4. Choi Y, Sim S, Park HS. Distinct functions of eosinophils in severe asthma with type 2 phenotype: clinical implications. Korean J Intern Med 2020;35:823–833.

5. McBrien CN, Menzies-Gow A. The biology of eosinophils and their role in asthma. Front Med (Lausanne) 2017;4:93.

6. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520–532.

7. Liu JN, Shin YS, Yoo HS, et al. The prevalence of serum specific IgE to superantigens in asthma and allergic rhinitis patients. Allergy Asthma Immunol Res 2014;6:263–266.

8. Xu SX, McCormick JK. Staphylococcal superantigens in colonization and disease. Front Cell Infect Microbiol 2012;2:52.

9. Du K, Zhao Y, Zhang X, et al. Staphylococcus aureus lysate induces an IgE response via memory B cells in nasal polyps. J Allergy Clin Immunol 2024;153:718–731.e11.

10. Ong PY, Patel M, Ferdman RM, Dunaway T, Church JA. Association of staphylococcal superantigen-specific immunoglobulin e with mild and moderate atopic dermatitis. J Pediatr 2008;153:803–806.

11. Li H, Llera A, Malchiodi EL, Mariuzza RA. The structural basis of T cell activation by superantigens. Annu Rev Immunol 1999;17:435–466.

12. Zhang N, Holtappels G, Gevaert P, et al. Mucosal tissue polyclonal IgE is functional in response to allergen and SEB. Allergy 2011;66:141–148.

13. Flora M, Perrotta F, Nicolai A, et al. Staphylococcus Aureus in chronic airway diseases: an overview. Respir Med 2019;155:66–71.

14. Kowalski ML, Cieślak M, Pérez-Novo CA, Makowska JS, Bachert C. Clinical and immunological determinants of severe/refractory asthma (SRA): association with Staphylococcal superantigen-specific IgE antibodies. Allergy 2011;66:32–38.

15. Matsumoto H, Kanemitsu Y, Nagasaki T, et al. Staphylococcus aureus enterotoxin sensitization involvement and its association with the CysLTR1 variant in different asthma phenotypes. Ann Allergy Asthma Immunol 2017;118:197–203.

16. Song WJ, Sintobin I, Sohn KH, et al. Staphylococcal enterotoxin IgE sensitization in late-onset severe eosinophilic asthma in the elderly. Clin Exp Allergy 2016;46:411–421.

17. Chung KF. Staphylococcus aureus enterotoxin-specific IgE sensitization in severe eosinophilic asthma phenotype. Allergy Asthma Immunol Res 2023;15:119–121.

18. Global Initiative for Asthma. 2023 GINA report, global strategy for asthma management and prevention [Internet]. Fontana (WI): Global Initiative for Asthma, c2023 [cited 2023 Dec 27]. Available from: https://ginasthma.org/2023-gina-mainreport/. 19. Holguin F, Cardet JC, Chung KF, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J 2020;55:1900588.

20. Woo SD, Yang EM, Jang J, et al. Serum-free immunoglobulin E: a useful biomarker of atopy and type 2 asthma in adults with asthma. Ann Allergy Asthma Immunol 2021;127:109–115.e1.

21. Bachert C, Zhang N. Chronic rhinosinusitis and asthma: novel understanding of the role of IgE ‘above atopy’. J Intern Med 2012;272:133–143.

22. Pinheiro-Torres AS, Ferreira-Duarte AP, Takeshita WM, et al. Airways exposure of bacterial superantigen SEB enhances bone marrow eosinophil population and facilitates its egress to blood and lung tissue. Life Sci 2021;264:118685.

23. Hellings PW, Hens G, Meyts I, et al. Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B. Clin Exp Allergy 2006;36:1063–1071.

24. Abdurrahman G, Schmiedeke F, Bachert C, Bröker BM, Holtfreter S. Allergy-a new role for T cell superantigens of Staphylococcus aureus? Toxins (Basel) 2020;12:176.

25. Huvenne W, Callebaut I, Plantinga M, et al. Staphylococcus aureus enterotoxin B facilitates allergic sensitization in experimental asthma. Clin Exp Allergy 2010;40:1079–1090.

26. Schleich F, Moermans C, Gerday S, et al. Patients with asthma only sensitized to Staphylococcus aureus enterotoxins have more exacerbations, airflow limitation, and higher levels of sputum IL-5 and IgE. J Allergy Clin Immunol Pract 2023;11:3055–3061.e4.

27. Bachert C, van Steen K, Zhang N, et al. Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. J Allergy Clin Immunol 2012;130:376–381.e8.

28. Matucci A, Vultaggio A, Maggi E, Kasujee I. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? Respir Res 2018;19:113.

29. Lee Y, Lee JH, Yang EM, et al. Serum levels of eosinophil-derived neurotoxin: a biomarker for asthma severity in adult asthmatics. Allergy Asthma Immunol Res 2019;11:394–405.

30. Koh GC, Shek LP, Goh DY, Van Bever H, Koh DS. Eosinophil cationic protein: is it useful in asthma? A systematic review. Respir Med 2007;101:696–705.

31. Price D, Wilson AM, Chisholm A, et al. Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy 2016;9:1–12.

32. Zeiger RS, Schatz M, Dalal AA, et al. Blood eosinophil count and outcomes in severe uncontrolled asthma: a prospective study. J Allergy Clin Immunol Pract 2017;5:144–153.e8.

33. Solomon Y, Malkamu B, Berhan A, et al. Peripheral blood eosinophilia in adult asthmatic patients and its association with the severity of asthma. BMC Pulm Med 2023;23:96.

34. Kimura H, Konno S, Makita H, et al. Prospective predictors of exacerbation status in severe asthma over a 3-year follow-up. Clin Exp Allergy 2018;48:1137–1146.

35. Choi Y, Kim YM, Lee HR, et al. Eosinophil extracellular traps activate type 2 innate lymphoid cells through stimulating airway epithelium in severe asthma. Allergy 2020;75:95–103.

36. Choi Y, Le Pham D, Lee DH, Lee SH, Kim SH, Park HS. Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma. Exp Mol Med 2018;50:1–8.

37. Gevaert E, Zhang N, Krysko O, et al. Extracellular eosinophilic traps in association with Staphylococcus aureus at the site of epithelial barrier defects in patients with severe airway inflammation. J Allergy Clin Immunol 2017;139:1849–1860.e6.

38. Kim SH, Yang SY, You J, et al. Association of specific immunoglobulin E to staphylococcal enterotoxin with airway hyperresponsiveness in asthma patients. Tuberc Respir Dis (Seoul) 2016;79:295–301.

39. Barranco P, Palao P, Ruiz I, et al. Relationship between IgE-mediated sensitization to Staphylococcus aureus enterotoxin B, asthma severity, and atopy. J Investig Allergol Clin Immunol 2021;31:170–173.

40. Tanaka A, Suzuki S, Ohta S, et al. Association between specific IgE to Staphylococcus aureus enterotoxins A and B and asthma control. Ann Allergy Asthma Immunol 2015;115:191–197.e2.

41. Elabras J Filho, Mello FC, Lupi O, Bica BE, Papi JA, França AT. Staphylococcal superantigen-specific IgE antibodies: degree of sensitization and association with severity of asthma. J Bras Pneumol 2016;42:356–361.